News

Nanotubes shred tumors in mice

Magnetic carbon nanotubes treat drug-resistant glioblastoma in mice, but hurdles remain for human translation.
Written byDanielle Sedbrook, PhD
| 4 min read
An immunofluorescence image of a mouse brain with a glioblastoma tumor and a carbon nanotube-based treatment.

Researchers imaged mouse brain tissue (blue) containing a glioblastoma tumor (green) 24 hours after injecting magnetic carbon nanotubes (red) into the tumor region.

Credit: Xian Wang

A glioblastoma diagnosis is tantamount to a death sentence. Most patients survive just over one year with this aggressive brain cancer. Treatment options are limited, and mortality rates have not improved for decades.

The majority of glioblastoma patients undergo surgery and then receive radiation therapy and temozolamide, the only FDA approved chemotherapy that stops the cancer’s growth. A wearable device called the Optune device extends the life of some patients with electric fields that slow cancer cell proliferation. But eventually, almost all glioblastoma patients develop resistance to both radiation and temozolamide.

Applying a rotating magnetic field to magnetic carbon nanotubes inside a cancer cell causes the nanotubes to move.
Movie Credit: Xian Wang

Recently, an interdisciplinary team of scientists from the University of Toronto and the Hospital for Sick Children in Toronto reported an “outside-the-box” treatment for glioblastoma. Described in Science Advances, their method shows promise in a preclinical mouse model. It may provide hope for patients who once had none, but only if it can be translated into humans.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular visualization of a protein structure, rendered in a ribbon diagram style.
A comparative structural analysis of MC4R complexes reveals how agonist binding influences receptor conformation, ligand interactions, and complex stability.
Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.